https://www.selleckchem.com/products/eht-1864.html
Insomnia is a debilitating symptom experienced by nearly 60% of cancer survivors. Building on our prior research showing the clinical benefit of cognitive behavioral therapy for insomnia (CBT-I) and acupuncture, we organized a workshop of patient advocates and clinician stakeholders to understand the barriers and develop recommendations for the dissemination and implementation of these interventions. Participants completed a pre-workshop survey assessing their experiences with insomnia and barriers to insomnia treatment and participate